Product Images Rabeprazole Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Rabeprazole Sodium NDC 62175-302 by Lannett Company, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - rabeprazole sodium delayed release tablets 1

Figure 1 - rabeprazole sodium delayed release tablets 1

Figure 2 - rabeprazole sodium delayed release tablets 2

Figure 2 - rabeprazole sodium delayed release tablets 2

This appears to be a table displaying data from a study comparing the effectiveness of a placebo treatment to two different doses of a medication for heartburn. The treatments being studied are referred to as "PLACEBO," "RAB 10mg," and "RAB 20mg" and the number of participants in each treatment group is also listed. The table has columns for "DAY," with dates displayed, and "Heartburn Scores," which are measured on a scale from 0 (no heartburn) to 4 (very severe heartburn).*

Figure 3 - rabeprazole sodium delayed release tablets 3

Figure 3 - rabeprazole sodium delayed release tablets 3

This text appears to be the results of a study or clinical trial comparing the effects of a placebo and two different doses of a drug called RAB. The sample sizes for each group are listed, with 68 participants in the placebo group, 64 participants in the RAB 10mg group, and 67 participants in the RAB 20mg group.*

Figure 4 - rabeprazole sodium delayed release tablets 4

Figure 4 - rabeprazole sodium delayed release tablets 4

Figure 5 - rabeprazole sodium delayed release tablets 5

Figure 5 - rabeprazole sodium delayed release tablets 5

20 mg 30 count bottle label - rabeprazole sodium delayed release tablets 6

20 mg 30 count bottle label - rabeprazole sodium delayed release tablets 6

This is a medication called Rabeprazole Sodium sold as Loenzar Plus Tablet. The tablets have a concentration of 20 mg and are packaged in a container with NDC number 62175-302-32. It is advised to store the tablets at room temperature and protect them from moisture. Dispensing should be done in a tightly enclosed container for safekeeping. Detailed information on the dosage and use can be found in the accompanying prescription. The distributor of this medication is Print Medicafion Guides at Lomnet Company Inc. based in Philadelphia. The data provided was last revised in August 2020.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.